Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSage Group Regulatory News (SGE)

Share Price Information for Sage Group (SGE)

Share Price is delayed by 15 minutes
Get Live Data
883.20    30.00 (3.52%)
Bid:
880.60
Ask:
881.40
Spread: 0.80 (0.091%)
Market Cap: £7.96b
SGE Live PriceLast checked at - London Stock Exchange

Intraday Sage Group Share Chart

SHARE BUYBACK PROGRAMME

15 May 2025 07:00

RNS Number : 7298I
Sage Group PLC (The)
15 May 2025
 

THE SAGE GROUP PLC

SHARE BUYBACK PROGRAMME

 

Sage announces that it is extending its ongoing share buyback programme by up to £200 million.

London 15 May 2025 - The Sage Group plc ("Sage" or the "Group") today announces a share buyback programme extension for aggregate consideration of up to £200 million (the "Extended Programme") which will commence on completion of its ongoing share buyback programme for aggregate consideration of up to £400 million announced on 20 November 2024 (the "Initial Programme").

The Initial Programme is expected to end no later than 3 June 2025 (as previously announced) and, following its completion, the Extended Programme will commence. The Extended Programme is expected to end no later than 6 August 2025.

The Extended Programme is consistent with the Group's disciplined capital allocation policy, and reflects the Board's confidence in Sage's future prospects, together with Sage's strong cash generation and robust financial position. Sage continues to have considerable financial flexibility to drive the execution of its growth strategy.

Further details of the Extended Programme are set out below.

________________________________________

Enquiries

The Sage Group plc: +44 (0) 7341 479956

Caroline Xu, Group Finance

James Sandford, Investor Relations

David Ginivan, Corporate PR

FGS Global: +44 (0) 20 7251 3801

Conor McClafferty

Sophia Johnston

________________________________________

Further details of the Extended Programme

Sage has entered into non-discretionary arrangements with Morgan Stanley & Co. International plc ("Morgan Stanley") and J.P. Morgan Securities plc ("J.P. Morgan") (together, the "Brokers") in relation to the purchase by the Brokers, acting as riskless principals, of ordinary shares of Sage (the "Shares"). Morgan Stanley will conduct the first half of the Extended Programme and J.P. Morgan will conduct the second half. The Extended Programme will commence on the trading day after the Initial Programme is completed and, in any case, no later than 4 June 2025.

The Brokers will make trading decisions in relation to Shares purchased under the Extended Programme independently of, and uninfluenced by, Sage. The purpose of the Extended Programme is to reduce the share capital of Sage. The Brokers will make an on-sale of such Shares to Sage and all Shares repurchased will be cancelled.

Any purchases of Shares contemplated by this announcement will be carried out on the London Stock Exchange and/or other recognised investment exchange(s) and will be effected within certain pre-set parameters. These arrangements are in accordance with Sage's general authority to repurchase Shares granted at its latest Annual General Meeting, Chapter 9 of the UK Listing Rules, and those provisions of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and the Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and with regard to regulatory technical standards for the conditions applicable to buyback programmes.

The maximum number of Shares which may currently be purchased or committed to be purchased by Sage under the Extended Programme is 81,555,354, which is the maximum number remaining as of the date of this announcement pursuant to the relevant authorities granted by shareholders at Sage's latest Annual General Meeting.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFDFALEISEDI
Date   Source Headline
2nd Aug 20245:40 pmRNSDirector/PDMR Shareholding
1st Aug 20244:30 pmRNSHolding(s) in Company
31st Jul 20245:45 pmRNSTotal Voting Rights
30th Jul 20247:00 amRNSTrading update for nine months ended 30 June 2024
11th Jul 20245:00 pmRNSHolding(s) in Company
8th Jul 20245:00 pmRNSHolding(s) in Company
4th Jul 20245:59 pmRNSDirector/PDMR Shareholding
28th Jun 20245:45 pmRNSTotal Voting Rights
27th Jun 20245:30 pmRNSHolding(s) in Company
26th Jun 20244:30 pmRNSHolding(s) in Company
19th Jun 20241:00 pmRNSDirector/PDMR Shareholding
18th Jun 20245:00 pmRNSDirector/PDMR Shareholding
10th Jun 20245:50 pmRNSHolding(s) in Company
6th Jun 202410:00 amRNSBlock listing Interim Review
31st May 20245:48 pmRNSTotal Voting Rights
29th May 20244:15 pmRNSDirector/PDMR Shareholding
21st May 20245:33 pmRNSDirector/PDMR Shareholding
21st May 20245:21 pmRNSDirector/PDMR Shareholding
16th May 20247:00 amRNSResults for the six months to 31 March 2024
30th Apr 20245:55 pmRNSTotal Voting Rights
29th Apr 202410:07 amRNSDirector Declaration
11th Apr 20246:25 pmRNSTransaction in Own Shares
11th Apr 202412:35 pmRNSTotal Voting Rights: Correction
10th Apr 20246:23 pmRNSTotal Voting Rights
10th Apr 20246:12 pmRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20246:06 pmRNSTransaction in Own Shares
4th Apr 20245:42 pmRNSTransaction in Own Shares
3rd Apr 20245:56 pmRNSTransaction in Own Shares
2nd Apr 20246:13 pmRNSTransaction in Own Shares
28th Mar 20245:40 pmRNSTransaction in Own Shares
28th Mar 20244:46 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20246:08 pmRNSTransaction in Own Shares
25th Mar 20245:58 pmRNSTransaction in Own Shares
21st Mar 20246:11 pmRNSTransaction in Own Shares
21st Mar 20241:11 pmRNSDirector Declaration
20th Mar 20245:55 pmRNSTransaction in Own Shares
19th Mar 20245:50 pmRNSTransaction in Own Shares
18th Mar 20245:54 pmRNSTransaction in Own Shares
15th Mar 20246:12 pmRNSTransaction in Own Shares
14th Mar 20245:44 pmRNSTransaction in Own Shares
13th Mar 20246:18 pmRNSTransaction in Own Shares
12th Mar 20245:51 pmRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20246:03 pmRNSTransaction in Own Shares
7th Mar 20246:03 pmRNSTransaction in Own Shares
6th Mar 20245:51 pmRNSTransaction in Own Shares
5th Mar 20246:33 pmRNSTransaction in Own Shares
4th Mar 20245:20 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.